soul trial oral semaglutide cardiovascular outcomes results 2024 2025 nejm The impact of on events in patients with type 2 diabetes: review of from the soul trial oral semaglutide cardiovascular

[1] Additionally, GLP-1 receptor agonists including semaglutide are associated with an increased risk of gallbladder disease, which can present with right upper quadrant pain, fever, or jaundice

Ozempic Users Report Stomach Paralysis from Weight Loss Drug: So Much Hell Ever since Ozempic was first released to the public in 2018, the diabetic injectable has become a fan favorite for patients even those without diabetes to lose weight

You cannot measure GLP-1 receptor occupancy in the brain through a blood test

For individuals with preexisting conditions such as type 2 diabetes, this side effect may be particularly problematic